BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MGIC
4276
DELISTED
Magic Software Enterprises
MGIC
| $147K | ﹤0.01% |
12,997
+8,370
| +181% | +$82.3K |
|
4277
Zedge
ZDGE
$38.9M
| $146K | ﹤0.01% |
98,642
-310
| -0.3% | -$348 |
|
4278
LGL Group
LGL
$46.5M
| $145K | ﹤0.01% |
45,084
+10,738
| +31% | +$34.7K |
|
4279
Vanguard Dividend Appreciation ETF
VIG
$114B
| $145K | ﹤0.01% |
1,236
-1,300
| -51% | -$148K |
|
|
VIVE
4280
DELISTED
VIVEVE MED INC
VIVE
| $145K | ﹤0.01% |
25,795
+25,141
| +3,844% | +$158K |
|
|
CYPH
4281
Cypherpunk Technologies Inc
CYPH
$73.3M
| $144K | ﹤0.01% |
6,884
+2,989
| +77% | +$64.1K |
|
4282
Serina Therapeutics
SER
$36M
| $144K | ﹤0.01% |
4,321
-28,195
| -87% | -$830K |
|
|
WHWK
4283
Whitehawk Therapeutics
WHWK
$271M
| $143K | ﹤0.01% |
7,618
-4,125
| -35% | -$54K |
|
4284
Ocugen
OCGN
$434M
| $142K | ﹤0.01% |
645,985
| – | – |
|
4285
Mind CTI
MNDO
$20.6M
| $141K | ﹤0.01% |
67,045
+17,005
| +34% | +$31.4K |
|
|
NOTV
4286
DELISTED
Inotiv
NOTV
| $139K | ﹤0.01% |
27,654
+20,830
| +305% | +$95.9K |
|
|
BPMP
4287
DELISTED
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
| $139K | ﹤0.01% |
12,120
-281,838
| -96% | -$3.22M |
|
|
MSBF
4288
DELISTED
MSB Financial Corp.
MSBF
| $139K | ﹤0.01% |
12,266
+10,513
| +600% | +$124K |
|
|
TTPH
4289
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $138K | ﹤0.01% |
54,721
-15,078
| -22% | -$28.6K |
|
4290
Hennessy Advisors
HNNA
$78.5M
| $134K | ﹤0.01% |
16,921
+345
| +2% | +$2.75K |
|
|
SYNC
4291
DELISTED
Synacor, Inc.
SYNC
| $134K | ﹤0.01% |
118,328
+21,060
| +22% | +$25.7K |
|
|
COE
4292
51Talk Online Education Group
COE
$117M
| $133K | ﹤0.01% |
+1,295
| New | +$129K |
|
|
SSKN
4293
DELISTED
Strata Skin Sciences
SSKN
| $133K | ﹤0.01% |
11,631
+651
| +6% | +$7.72K |
|
4294
Natural Alternatives International
NAII
$14.9M
| $132K | ﹤0.01% |
19,221
+5,503
| +40% | +$37.4K |
|
|
ARDS
4295
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
| $131K | ﹤0.01% |
19,628
+13,343
| +212% | +$92.1K |
|
4296
Air Industries Group
AIRI
$12.8M
| $129K | ﹤0.01% |
10,801
+3,928
| +57% | +$44K |
|
4297
Battalion Oil
BATL
$28.8M
| $129K | ﹤0.01% |
13,578
+10,892
| +406% | +$69.7K |
|
4298
Invesco FTSE RAFI US 1000 ETF
PRF
$10B
| $129K | ﹤0.01% |
5,955
+1,800
| +43% | +$37.5K |
|
|
CCEC
4299
Capital Clean Energy Carriers
CCEC
$1.35B
| $128K | ﹤0.01% |
15,830
+11,104
| +235% | +$92.2K |
|
|
RTW
4300
DELISTED
RTW Retailwinds, Inc.
RTW
| $128K | ﹤0.01% |
639,216
-1,439,681
| -69% | -$424K |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.